NOVABAY PHARMACEUTICALS INC (NBY)
US66987P3001 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to NBY. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.72. This target is 4473.71% above the current price.
NBY was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NBY.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed NBY. So this is just the average opinion of a couple of analysts.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-11 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2022-05-20 | Ascendiant Capital | Maintains | Buy |